EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis

Wen-Wen Tsai iD, Kuan-Hsien Lu, Kuan-Hung Lin, Jheng-Yan Wu, Chih-Cheng Lai, Kuo Chuan Hung, Yi-Ting Tsai, Meng-Tsang Hsieh

Therapeutic Advances in Neurological Disorders · 2026-08 · 19

DOI: 10.1177/17562864261474987 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 03.08.2026. Verfasst von Wen-Wen Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Chi-Mei Medical Center, Tainan, Taiwan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In the contemporary endovascular thrombectomy (EVT) era, treatment decisions are often made without routine perfusion imaging. However, perfusion remains central to intravenous thrombolysis (IVT) beyond 4.5 hours. Evidence across extended and very late windows remains uncertain.

Objectives

To evaluate the efficacy and safety of perfusion-guided IVT beyond 4.5 hours after acute ischemic stroke and to assess the robustness of evidence across the 4.5–9 hour and 9–24 hour windows.

Design

Time-stratified systematic review and meta-analysis of phase III randomized controlled trials. Data Sources and Methods We systematically searched PubMed, Embase, and the Cochrane Library from inception to February 8, 2026. Phase III randomized controlled trials enrolling perfusion-selected AIS patients treated 4.5–24 hours from last known well were included; trials permitting stratification into 4.5–9 and 9–24 hours were prioritized. Outcomes included 90 days excellent outcome (mRS 0–1), favorable (mRS 0–2), good (mRS 0–3), mortality, and symptomatic intracerebral hemorrhage (sICH). Random-effects meta-analysis and trial sequential analysis (TSA) were performed.

Results

Five randomized controlled trials (n=1,798) were included. IVT increased excellent outcome in both the 4.5–9 hour window (n=866; RR 1.30, 95% CI 1.08–1.56; I 2 =0%; absolute risk difference (ARD)=9.1%; NNT=11) and the 9–24 hour window (n=563; RR 1.41, 95% CI 1.10–1.79; I 2 =0%; ARD=11.1%; NNT=9). Across 4.5–24 hours, IVT improved favorable (RR 1.18, 95% CI 1.07–1.29; I 2 =0%) and good outcomes (RR 1.11, 95% CI 1.03–1.21; I 2 =0%), with no significant effect on mortality (RR 1.14, 95% CI 0.85–1.52; I 2 =0%). IVT increased sICH risk overall (RR 5.63, 95% CI 2.17–14.57; I 2 =0%; ARD=approximately 3.0%; NNH=33). TSA suggested that the cumulative evidence has not yet reached the required information size for firm conclusiveness.

Conclusion

In the contemporary EVT era, perfusion-guided IVT may remain clinically relevant for selected patients treated beyond 4.5 hours, particularly those not eligible for thrombectomy or without immediate EVT access. Current phase III randomized evidence suggests improved functional outcomes but increased symptomatic intracerebral hemorrhage. However, TSA indicates that the evidence remains underpowered for definitive conclusions. Evidence for the 9–24 hour window is particularly limited and derived from China-based trials; therefore, these findings should be interpreted as hypothesis-supporting rather than conclusive.

Schlagwörter

Stichwörter der Autor:innen

acute ischemic strokemeta-analysisperfusion imagingthrombolysistime windowtrial sequential analysis

Autor:innen und Institutionen

  • Department of Neurology, Chi-Mei Medical Center, Tainan, Taiwan.
  • Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.
  • School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.

ORCID-Profile: Wen-Wen Tsai

Zitieren

APA

Tsai, W. W., Lu, K. H., Lin, K. H., Wu, J. Y., Lai, C. C., Hung, K. C., Tsai, Y. T., & Hsieh, M. T. (2026). Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261474987

Vancouver

Tsai WW, Lu KH, Lin KH, Wu JY, Lai CC, Hung KC, et al. Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261474987

BibTeX
@article{Tsai2026,
  author = {Tsai, Wen-Wen and Lu, Kuan-Hsien and Lin, Kuan-Hung and Wu, Jheng-Yan and Lai, Chih-Cheng and Hung, Kuo Chuan and Tsai, Yi-Ting and Hsieh, Meng-Tsang},
  title = {Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2026},
  volume = {19},
  doi = {10.1177/17562864261474987}
}
Kostenlos starten →